Journal Article

Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines

Stockler, Martin R., Livingstone, Ann, Morton, Rachael L., Beale, Philip J., Karikios, Deme J., Agarwal, Anupriya

2021

Overview

Background Optimising the care of individuals with cancer without imposing significant financial burden related to their anticancer treatment is becoming increasingly difficult. The American Society of Clinical Oncology (ASCO) has recommended clinicians discuss costs of cancer care with patients to enhance shared decision-making. We sought information to guide oncologists’ discussions with patients about these costs. Methods We searched Medline, EMBASE and clinical practice guideline databases from January 2009 to 1 June 2019 for recommendations about discussing the costs of care and financial burden. Guideline quality was assessed with the AGREE-II instrument. Results Twenty-seven guidelines met our eligibility criteria, including 16 from ASCO (59%). 21 of 27 (78%) guidelines included recommendations about discussion or consideration of treatment costs when prescribing, with information about actual costs in four (15%). Recognition of the risk of financial burden or financial toxicity was described in 81% (22/27) of guidelines. However, only nine guidelines (33%) included information about managing the financial burden. Conclusions Current clinical practice guidelines have little information to guide physician-patient discussions about costs of anticancer treatment and management of financial burden. This limits patients’ ability to control costs of treatment, and for the healthcare team to reduce the incidence and severity of financial burden. Current guidelines recommend clinician awareness of price variability and high costs of treatment. Clinicians are recommended to explore cost concerns and address financial worries, especially in high risk groups. Future guidelines should include advice on facilitating cost transparency discussions, with provision of cost information and resources.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Biomedical and Life Sciences / Biomedicine / Cancer / cancer burden and supportive therapy / cancer costs / Cancer patients / Cancer Research / Cancer therapies / Care and treatment / Clinical medicine / Communication / Cost discussions / Cost estimates / Costs of care / Decision making / Finance / Financial toxicity / Guidelines / Health Promotion and Disease Prevention / Medical care, Cost of / Medicine/Public Health / Oncology / Oncology, Experimental / Palliative care / Patients / Physician and patient / Physicians / Practice guidelines (Medicine) / Research Article / Risk groups / Shared decision making / Surgical Oncology / Survivorship / Systematic review / Text analysis / Toxicity